News
MOLN
3.215
0.00%
0.000
Molecular Partners presents new MP0632 clinical data at SITC conference
TipRanks · 3d ago
Molecular Partners Says MP0632 Preclinical Data At SITC 2026 Show No Detectable Impact On Healthy Mesothelial Or Epithelial Cells, Supporting IND-Enabling Studies In MSLN And EpCAM Solid Tumors
Benzinga · 3d ago
After Plunging 18.3% in 4 Weeks, Here's Why the Trend Might Reverse for Molecular Partners AG Sponsored ADR (MOLN)
NASDAQ · 4d ago
Molecular Partners’ Focused Radio-DARPin Strategy and Clinical Catalysts Support $13 Valuation
TipRanks · 6d ago
Weekly Report: what happened at MOLN last week (1026-1030)?
Weekly Report · 11/02 09:50
Molecular Partners reports Q3 results
Seeking Alpha · 10/29 17:25
Molecular Partners Q3 EPS $(0.38) Beats $(0.46) Estimate
Benzinga · 10/29 13:50
Molecular Partners AG Announces Strategic Shift to Radiopharmaceuticals and Intends to Reduce Workforce by No More Than 55 Positions
NASDAQ · 10/29 11:42
Molecular Partners Deepens Radiopharmaceutical Focus and Launches Major Restructuring on Q3 2026 Results
TipRanks · 10/29 10:35
Weekly Report: what happened at MOLN last week (1019-1023)?
Weekly Report · 10/26 09:50
Molecular Partners selects MP0730 as lead Radio-DARPin candidate
TipRanks · 10/22 09:45
Weekly Report: what happened at MOLN last week (1012-1016)?
Weekly Report · 10/19 09:50
Weekly Report: what happened at MOLN last week (1005-1009)?
Weekly Report · 10/12 09:53
Weekly Report: what happened at MOLN last week (0928-1002)?
Weekly Report · 10/05 09:53
Weekly Report: what happened at MOLN last week (0921-0925)?
Weekly Report · 09/28 09:50
Molecular Partners’ MP0533 Trial Completion: What AML Data Could Mean for MOLN Investors
TipRanks · 09/25 16:30
Weekly Report: what happened at MOLN last week (0914-0918)?
Weekly Report · 09/21 09:50
Weekly Report: what happened at MOLN last week (0907-0911)?
Weekly Report · 09/14 09:53
Weekly Report: what happened at MOLN last week (0831-0904)?
Weekly Report · 09/07 09:49
Clear Street transfers coverage on Molecular Partners, keeps Buy rating
TipRanks · 09/04 20:15
More
Webull provides a variety of real-time MOLN stock news. You can receive the latest news about MOLECULAR PARTNERS AG through multiple platforms. This information may help you make smarter investment decisions.
About MOLN
Molecular Partners AG is a Switzerland-based clinical-stage biotech company developing DARPin (Designed Ankyrin Repeat Proteins) a new class of custom-built protein therapeutics based on natural binding proteins that open a new dimension of multi-functionality and multi-target specificity in drug design. The Company has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics , and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.